Jaipur (Rajasthan) [India], February 28: Amity University Rajasthan (AUR) successfully hosted its much-awaited Convocation Ceremony for the Class of 2024, on 25th February 2025, a grand occasion ...

Dr. Reddy's Laboratories Ltd. closed 18.05% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

Dr. Reddy's Laboratories Ltd. closed 16.87% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy's Laboratories, USA, a wholly owned subsidiary of the company, has successfully completed the sale of all issued ...

Natixis Advisors LLC increased its position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 422.7% in the 4th quarter, according to the company in its most recent filing with ...

Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. Food and Drug Administration, FDA, has accepted a 351(k) Biologic ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of biosimilars, and Dr Reddy’s Laboratories SA, a wholly-owned subsidiary of Dr Reddy’s Laboratories ...

In this article, we are going to take a look at where Dr. Reddy’s Laboratories Limited (NYSE:RDY) stands against other best weight loss drug stocks to buy according to analysts.

Guangzhou, China-based commercial-stage biopharmaceutical firm Bio-Thera Solutions and Hyderabad-based Dr. Reddy’s Laboratories, through one of its subsidiaries, signed commercialisation and ...